FDA Approved: OXYTROL — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved Allergan's OXYTROL (oxybutynin) supplemental application, enabling a label modification for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• OXYTROL (OXYBUTYNIN)

Snippet

SUPPL AP for OXYTROL (OXYBUTYNIN)